Kodiak Sciences Inc (KOD)

83.99 -5.63  -6.28% NASDAQ Dec 3, 16:00 84.00 +0.01  +0.01% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All KOD News

News

View All Events

Events

Date Type Description
03/01/2022 Earnings Results Q4 2021 Earnings Results
11/09/2021 Earnings Results Q3 2021 Earnings Results
08/09/2021 Earnings Results Q2 2021 Earnings Results
06/07/2021 12:00 EST AGM 2020 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
03/01/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Kodiak Sciences Inc is a clinical-stage company. It is engaged in developing innovative therapeutics to treat the high prevalence of ophthalmic diseases. The most advanced product candidate of the group is KSI-301, a biologic therapy built with an antibody biopolymer conjugate platform, which is designed to maintain potent and effective drug levels in ocular tissue.
  • URL: https://www.kodiak.com
  • Investor Relations URL: https://ir.kodiak.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Mar. 01, 2022
  • Last Earnings Release: Nov. 09, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
SBIO ALPS Medical Breakthroughs ETF 3.10%
BBC Virtus LifeSci Biotech Clinical Trls ETF 0.73%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.